The Circular RNA Cdr1as Act as an Oncogene in Hepatocellular Carcinoma through Targeting miR-7 Expression

CircRNAs are a class of endogenous RNA that regulates gene expression at the post-transcriptional or transcriptionallevel through interacting with other molecules or microRNAs. Increasing studies have demonstrated that circRNAs play a crucial role in biology processes. CircRNAs are proved as potentialbiomarkers in many diseases including cancers. However, the role of Cdr1as in Hepatocellular carcinoma (HCC) remains to be elucidated. We demonstrated that Cdr1as expression was upregulated in HCC tissues compared with the adjacent non-tumor tissues. In addtion, miR-7 expression was downregulated in HCC tissues compared with the adjacent non-tumor tissues. Moreover, the expression level of miR-7 was inversely correlated with that in HCC tissues. Knockdown of Cdr1as suppressed the HCC cell proliferation and invasion. Overexpression of miR-7 inhibited the HCC cell proliferation and invasion. Overexpression of miR-7 could suppress the direct target gene CCNE1 and PIK3CD expression. Knockdown of Cdr1as suppressed the expression of miR-7 and also inhibited the CCNE1 and PIK3CD expression. Furthermore, knockdown of Cdr1as suppressed the HCC cell proliferation and invasion through targeting miR-7. These data suggested that Cdr1as acted as an oncogene partly through targeting miR-7 in HCC.

Abstract licence: CC BY

We don’t show the text of a retracted or withdrawn paper. The record stays, so citations to it can be checked.

1. 2.

   The circular RNA Cdr1as, via miR-7 and its targets, regulates insulin transcription and secretion in islet cells · 2015

2. 22.

   The Tumor-Suppressive miR-497-195 Cluster Targets Multiple Cell-Cycle Regulators in Hepatocellular Carcinoma · 2013

3. 24.

   Circular RNA (circRNA) in Alzheimer's disease (AD) · 2013

4. 26.

   Spatio-temporal regulation of circular RNA expression during porcine embryonic brain development · 2015

5. 30.

   Transcriptome-wide investigation of circular RNAs in rice · 2015

29 more references, whose wording the paper’s licence keeps private.

• Going circular: history, present, and future of circRNAs in cancer · 2023

• The role of lncRNA-mediated ceRNA regulatory networks in pancreatic cancer · 2022

• CircRNAs: role in human diseases and potential use as biomarkers · 2021

• Corrected

  Role of non-coding RNA networks in leukemia progression, metastasis and drug resistance · 2020

• GCNCDA: A new method for predicting circRNA-disease associations based on Graph Convolutional Network Algorithm. · 2020

  Not checked

• CircRNA inhibits DNA damage repair by interacting with host gene · 2020

• The emerging roles and functions of circular RNAs and their generation · 2019

• CircRNA-5692 inhibits the progression of hepatocellular carcinoma by sponging miR-328-5p to enhance DAB2IP expression · 2019

• Biogenesis, functions and clinical significance of circRNAs in gastric cancer · 2019

• The circ RNA –micro RNA code: emerging implications for cancer diagnosis and treatment · 2019

• Circular RNAs: a new frontier for cancer diagnosis and therapy · 2018

• Corrected

  Circular RNAs in Cancer – Lessons Learned From microRNAs · 2018

• Noncoding RNA:RNA Regulatory Networks in Cancer · 2018

• Function and clinical significance of circRNAs in solid tumors · 2018

• Circular RNA circ-ITCH inhibits bladder cancer progression by sponging miR-17/miR-224 and regulating p21, PTEN expression · 2018

• Circular RNAs: Characteristics, Function and Clinical Significance in Hepatocellular Carcinoma · 2018

• Circular RNAs function as ceRNAs to regulate and control human cancer progression · 2018

• Circular RNAs: emerging cancer biomarkers and targets · 2017

• Circular RNAs: Biogenesis, Function, and a Role as Possible Cancer Biomarkers · 2017

• Circular RNAs: Biogenesis, Function and Role in Human Diseases · 2017

and 3 more

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.